Notably, serum citrullinated vimentin (VICM) levels serve as a biomarker of disease activity in systemic sclerosis, showing significantly elevated concentrations in patients with rapid disease progression compared to healthy controls (24). The gene discussed is VIM; the disease is systemic sclerosis.